Literature DB >> 33654960

Calvarial Bone Implantation and in vivo Imaging of Tumor Cells in Mice.

Kyoko Hashimoto1, Shingo Sato1,2, Hiroki Ochi1, Shu Takeda3, Mitsuru Futakuchi4.   

Abstract

Bone is one of common metastasis sites for many types of cancer. In bone metastatic microenvironment, tumor-bone interactions play a significant role in the regulation of osteolytic or osteoblastic bone metastasis. In order to investigate the direct interaction between tumor cells and bone tissue, it is essential to generate appropriate animal models that mimic the behavior of tumor cells in bone metastatic lesions. Calvarial implantation model (bone invasion model) is a newly-established animal model that accurately recapitulates the behavior of tumor cells in the tumor-bone microenvironment. The surgical technique for tumor cell implantation is simpler than intracardiac, intra-arterial, or intraosseous injection techniques. This model can be useful for the identification of key factors driving tumor-induced osteolytic or osteoblastic changes.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Calvaria implantation model; Osteoblastic bone metastasis; Osteolytic bone metastasis; Tumor cell implantation; Tumor microenvironment; Tumor-bone interaction

Year:  2019        PMID: 33654960      PMCID: PMC7854057          DOI: 10.21769/BioProtoc.3151

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  8 in total

1.  Effect of three types of mixed anesthetic agents alternate to ketamine in mice.

Authors:  Sumiko Kawai; Yasuhiro Takagi; Shiro Kaneko; Tsutomu Kurosawa
Journal:  Exp Anim       Date:  2011

2.  Lack of prophylactic effect of incadronate on skeletal lesions associated with implants of prostate cancer.

Authors:  Atsuya Hikosaka; Mitsuru Futakuchi; Tadashi Ogiso; Shugo Suzuki; Kenjiro Kohri; Tomoyuki Shirai
Journal:  Eur Urol       Date:  2005-11-08       Impact factor: 20.096

3.  MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.

Authors:  Conor C Lynch; Atsuya Hikosaka; Heath B Acuff; Michelle D Martin; Noriyasu Kawai; Rakesh K Singh; Tracy C Vargo-Gogola; Jennifer L Begtrup; Todd E Peterson; Barbara Fingleton; Tomoyuki Shirai; Lynn M Matrisian; Mitsuru Futakuchi
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

4.  Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment.

Authors:  Shinya Sato; Mitsuru Futakuchi; Kumiko Ogawa; Makoto Asamoto; Kimihisa Nakao; Kiyofumi Asai; Tomoyuki Shirai
Journal:  Cancer Sci       Date:  2008-02       Impact factor: 6.716

5.  Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation.

Authors:  Mitsuru Futakuchi; Kalyan C Nannuru; Michelle L Varney; Anguraj Sadanandam; Kimihisa Nakao; Kiyofumi Asai; Tomoyuki Shirai; Shin-ya Sato; Rakesh K Singh
Journal:  Cancer Sci       Date:  2008-11-25       Impact factor: 6.716

6.  Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.

Authors:  Thomas J Wilson; Kalyan C Nannuru; Mitsuru Futakuchi; Anguraj Sadanandam; Rakesh K Singh
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

7.  Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.

Authors:  Kyoko Hashimoto; Hiroki Ochi; Satoko Sunamura; Nobuyoshi Kosaka; Yo Mabuchi; Toru Fukuda; Kenta Yao; Hiroaki Kanda; Keisuke Ae; Atsushi Okawa; Chihiro Akazawa; Takahiro Ochiya; Mitsuru Futakuchi; Shu Takeda; Shingo Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

8.  Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment.

Authors:  Mitsuru Futakuchi; Takao Nitanda; Saeko Ando; Harutoshi Matsumoto; Eri Yoshimoto; Katsumi Fukamachi; Masumi Suzui
Journal:  Int J Mol Sci       Date:  2018-03-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.